title: Pituitary apoplexy induced by triptorelin in patient with prostate cancer.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España. Electronic address: fguerrerop@bellvitgehospital.cat.
authors.forename: Fernando
authors.initials: F
authors.lastname: Guerrero-Pérez
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Agustina Pia
authors.initials: AP
authors.lastname: Marengo
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Alejandra
authors.initials: A
authors.lastname: Planas-Vilaseca
authors.affiliation: Medicina de Familia, Centro de Atención Primaria La Gavarra, Cornellá de Llobregat, Barcelona, España.
authors.forename: Vanesa
authors.initials: V
authors.lastname: Flores-Escobar
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Carles
authors.initials: C
authors.lastname: Villabona-Artero
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000236:Adenoma / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology; D006261:Headache / Q000209:etiology*; D006801:Humans; D007016:Hypophysectomy; D008279:Magnetic Resonance Imaging; D008297:Male; D009378:Neoplasms, Multiple Primary; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D010899:Pituitary Apoplexy / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D017329:Triptorelin Pamoate / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate